Delivery Order SPE2DB22D3009-SPE2DB26FAG98
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,899.74 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order valued at $4,416.12 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count packages) on August 20, 2025, with a completion date of August 21, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,367.15 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count) on August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the awardee's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) with a contract ceiling value of $12,962.44. This competitively awarded, firm fixed-price delivery order is set to conclude on October 30, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,256.08 to AmerisourceBergen Drug Corp for 100 tablets of Nucynta 50 mg on October 30, 2025, with completion scheduled for October 31, 2025. This competitive award, issued under firm fixed-price terms with no set-aside designation, represents a single delivery order fulfilling pharmaceutical supply requirements for federal medical procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $2,944.08 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count packages) with a completion date of August 11, 2025. This competitively awarded, non-set-aside contract operates under a firm fixed price arrangement and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Nucynta ER 200 mg tablets (60-count) valued at $2,965.27, with an ultimate completion date of September 29, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order falls under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Nucynta ER 150 mg tablets (60-count) on October 29, 2025, with a ceiling value of $2,576.36 and an ultimate completion date of October 30, 2025. This firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a delivery order valued at $6,667.68 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of October 23, 2025, and represents a non-set-aside procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Nucynta ER 50 mg tablets in quantities of 60 units. The contract carries a ceiling value of $1,414.00 and features firm fixed pricing with an ultimate completion date of July 25, 2025. This is a non-set-aside award issued competitively and represents a child contract under AmerisourceBergen's existing...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB26FAG98Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,806.87 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 50 mg tablets (60-count units). This firm fixed price contract, awarded on October 31, 2025, with an ultimate completion date of November 3, 2025, represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The Nucynta ER delivery exemplifies AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal military and veteran healthcare systems through the DLA Medical Supply Chain. As a major pharmaceutical distributor, the company maintains extensive federal contract portfolios covering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The competitive award of this pain management pharmaceutical underscores AmerisourceBergen's demonstrated capability to meet federal procurement requirements and its position as a primary vendor for comprehensive pharmaceutical support to Defense Health Agency customers and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 10/31/25 |